(ANSA) – WASHINGTON, February 27 – The US Food and Drug Administration (Fda) has authorized the emergency use of Johnson & Johnson’s single-dose vaccine. It is the third vaccine approved in the US after those of Pfizer-BioNTech and Moderna.
J&J has promised to provide the United States with 100 million doses of its vaccine by the end of June. These will add to the 600 million doses Pfizer-BioNTech and Moderna have committed to by the end of July. Overall, there would be enough doses to cover every adult American.
The Johnson & Johnson vaccine has been shown to have 72% efficacy in clinical trials in the US. (HANDLE).
REPRODUCTION RESERVED © Copyright ANSA